Researcher profile

Hernan Bazan

A native of Argentina, Dr. Hernan Bazan completed his undergraduate work at Vanderbilt University (B.S., 1994) and his medical school training at Georgetown University (M.D., 2000) in Washington DC. During his medical school training, he was a Howard Hughes Medical Institutes Research Scholar at the National Institutes of Health (HHMI-NIH Research Scholars Program) in Bethesda, MD (1996 - 1998). He conducted his General Surgery training at The Mount Sinai Hospital in New York (2000 - 2005) and his Vascular Surgery fellowship at Yale University/Yale-New Haven Hospital (2005 - 2007) in New Haven, CT. Dr. Bazan is a full-time practicing Board-certified in Vascular Surgery and is the author of over 45 peer-reviewed publications. He is also the Program Director for the Vascular Surgery Fellowship at the Ochsner Clinic. During his training, he was elected member of the medical honor society Alpha Omega Alpha (AOA), The Arnold P. Gold Foundation, and numerous vascular surgery societies. He was awarded the HHMI Continuing Medical Studies Award for the work he conducted during his time at the NIH. During his surgical residency at The Mount Sinai Hospital, Dr. Bazan was awarded the Arthur H. Aufses, Sr. Prize in Surgery by the faculty “for scholarship, integrity, concern for patients and outstanding ability as a teacher” and the Arthur H. Aufses, Jr. Prize by fellow junior surgical residents “for demonstrating overall excellence in surgical mentorship.” He has also received multiple teaching awards by medical students and fellow surgical residents at Mt. Sinai Hospital and the Ochsner Clinic. His areas of clinical interests are treatment of carotid artery disease/blockages with awake/cervical block and general anesthesia, carotid stenting, minimally invasive and open approaches to abdominal and thoracic aortic aneurysms, and the minimally invasive treatment of leg blockages, particularly in patients with critical limb ischemia. He has an active atherosclerosis translational research program on the mechanisms involved in carotid plaque rupture and stroke. He is the co-inventor of 5 patents and is the co-founder of a life sciences company aimed treating chronic pain thru safer novel non-narcotic molecules and a biotechnology company developing unique neuroprotection strategies for acute stroke.